a public good project by the
Synthesis
Company
of California

© 2026

Mario Salvi | doi.page

0 works0 citations0 h-index

Mario Salvi

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico(IT)

Publications by Year

Research Areas

Ophthalmology and Eye Disorders, Thyroid Disorders and Treatments, Pituitary Gland Disorders and Treatments, Glaucoma and retinal disorders, Growth Hormone and Insulin-like Growth Factors

Most-Cited Works

→ The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy(2016)941 cited
→ Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO(2008)791 cited
→ Teprotumumab for Thyroid-Associated Ophthalmopathy(2017)705 cited
→ Teprotumumab for the Treatment of Active Thyroid Eye Disease(2020)672 cited
→ Consensus Statement of the European Group on Graves' Orbitopathy (EUGOGO) on Management of Graves' Orbitopathy(2008)407 cited
→ Efficacy of B-Cell Targeted Therapy With Rituximab in Patients With Active Moderate to Severe Graves' Orbitopathy: A Randomized Controlled Study(2014)392 cited

→ Efficacy and Safety of Three Different Cumulative Doses of Intravenous Methylprednisolone for Moderate to Severe and Active Graves' Orbitopathy(2012)

357 cited

→ Treatment of Graves’ disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study(2007)262 cited

→ Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial(2018)214 cited